` TBRIF (Therma Bright Inc) vs S&P 500 Comparison - Alpha Spread

TBRIF
vs
S&P 500

Over the past 12 months, TBRIF has underperformed S&P 500, delivering a return of -46% compared to the S&P 500's +16% growth.

Stocks Performance
TBRIF vs S&P 500

Loading
TBRIF
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
TBRIF vs S&P 500

Loading
TBRIF
S&P 500
Difference
www.alphaspread.com

Performance By Year
TBRIF vs S&P 500

Loading
TBRIF
S&P 500
Add Stock

Competitors Performance
Therma Bright Inc vs Peers

Therma Bright Inc
Glance View

Market Cap
20.8m USD
Industry
Health Care

Therma Bright, Inc. develops and markets skin care medical device products. The company is headquartered in Toronto, Ontario. The company went IPO on 2001-07-11. The firm is a developer of the AcuVid COVID-19 Rapid Antigen Saliva Test and other diagnostic and medical device technologies that help test for illnesses and assist with pain management. The firm is focused on providing consumers and medical professionals with solutions that addresses medical and healthcare challenges. The company also provides a technology that delivers non-invasive, and pain-free skincare. Its product offerings include AcuVid, which is an antigen and antibody rapid screening test for COVID-19; Venowave, is a Deep Vein Thrombosis (DVT) prevention pump specifically designed for use at home; InterceptCS, is a system that provides controlled topical heat without the risk of burning the skin; Benepod, is a hot and cold contrast therapy device for pain relief without pain relieving medication, and TherOZap, provides pain management relief using thermal therapy for insect bites and stings.

TBRIF Intrinsic Value
0.0043 USD
Overvaluation 91%
Intrinsic Value
Price
Back to Top